Annual ROE
2.09%
-2.89%-58.03%
31 March 2024
Summary:
Takeda Pharmaceutical Company Limited annual return on equity is currently 2.09%, with the most recent change of -2.89% (-58.03%) on 31 March 2024. During the last 3 years, it has fallen by -5.73% (-73.27%). TAK annual ROE is now -88.78% below its all-time high of 18.63%, reached on 31 March 2003.TAK ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
4.01%
+1.98%+97.54%
01 September 2024
Summary:
Takeda Pharmaceutical Company Limited quarterly return on equity is currently 4.01%, with the most recent change of +1.98% (+97.54%) on 01 September 2024. Over the past year, it has increased by +1.05% (+35.47%). TAK quarterly ROE is now -76.63% below its all-time high of 17.16%, reached on 30 June 2009.TAK Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TAK ROE Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -58.0% | +35.5% |
3 y3 years | -73.3% | -58.1% |
5 y5 years | -43.7% | +83.1% |
TAK ROE High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -73.3% | at low | -58.1% | +97.5% |
5 y | 5 years | -73.3% | +132.2% | -58.1% | +1115.2% |
alltime | all time | -88.8% | +133.8% | -76.6% | +162.0% |
Takeda Pharmaceutical Company Limited ROE History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | 4.01%(+97.5%) |
June 2024 | - | 2.03%(-4.7%) |
Mar 2024 | 2.09%(-58.0%) | 2.13%(-20.2%) |
Dec 2023 | - | 2.67%(-9.8%) |
Sept 2023 | - | 2.96%(-36.1%) |
June 2023 | - | 4.63%(-7.2%) |
Mar 2023 | 4.98%(+13.7%) | 4.99%(+15.8%) |
Dec 2022 | - | 4.31%(+20.4%) |
Sept 2022 | - | 3.58%(+2.3%) |
June 2022 | - | 3.50%(-21.2%) |
Mar 2022 | 4.38%(-44.0%) | 4.44%(-48.8%) |
Dec 2021 | - | 8.67%(-9.4%) |
Sept 2021 | - | 9.57%(+7.5%) |
June 2021 | - | 8.90%(+11.9%) |
Mar 2021 | 7.82%(+768.9%) | 7.95%(+106.5%) |
Dec 2020 | - | 3.85%(+226.3%) |
Sept 2020 | - | 1.18%(-53.0%) |
June 2020 | - | 2.51%(+172.8%) |
Mar 2020 | 0.90%(-75.7%) | 0.92%(+178.8%) |
Dec 2019 | - | 0.33%(-84.9%) |
Sept 2019 | - | 2.19%(+14.7%) |
June 2019 | - | 1.91%(-61.8%) |
Mar 2019 | 3.71%(-59.9%) | 5.00%(-4.8%) |
Dec 2018 | - | 5.25%(-21.1%) |
Sept 2018 | - | 6.65%(+15.7%) |
June 2018 | - | 5.75%(-36.1%) |
Mar 2018 | 9.26%(+53.8%) | 9.00%(-4.6%) |
Dec 2017 | - | 9.43%(+14.6%) |
Sept 2017 | - | 8.23%(+0.1%) |
June 2017 | - | 8.22%(+34.3%) |
Mar 2017 | 6.02%(+63.6%) | 6.12%(-11.8%) |
Dec 2016 | - | 6.94%(-7.3%) |
Sept 2016 | - | 7.49%(-0.7%) |
June 2016 | - | 7.54%(+112.4%) |
Mar 2016 | 3.68% | 3.55%(-169.9%) |
Dec 2015 | - | -5.08%(-21.5%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2015 | - | -6.47%(+8.2%) |
June 2015 | - | -5.98%(+17.9%) |
Mar 2015 | -6.19%(-244.0%) | -5.07%(-338.0%) |
Dec 2014 | - | 2.13%(-42.3%) |
Sept 2014 | - | 3.69%(-15.6%) |
June 2014 | - | 4.37%(-2.9%) |
Mar 2014 | 4.30%(-38.8%) | 4.50%(-25.2%) |
Dec 2013 | - | 6.02%(+29.2%) |
Sept 2013 | - | 4.66%(+2.6%) |
June 2013 | - | 4.54%(-38.0%) |
Mar 2013 | 7.03%(+16.2%) | 7.32%(+45.0%) |
Dec 2012 | - | 5.05%(-5.1%) |
Sept 2012 | - | 5.32%(-20.5%) |
June 2012 | - | 6.69%(+11.7%) |
Mar 2012 | 6.05%(-48.7%) | 5.99%(-35.7%) |
Dec 2011 | - | 9.32%(-18.4%) |
Sept 2011 | - | 11.42%(-7.4%) |
June 2011 | - | 12.33%(+5.4%) |
Mar 2011 | 11.79%(-19.4%) | 11.70%(-3.5%) |
Dec 2010 | - | 12.13%(+1.1%) |
Sept 2010 | - | 12.00%(0.0%) |
June 2010 | - | 12.00%(-16.3%) |
Mar 2010 | 14.62%(+36.4%) | 14.33%(-9.1%) |
Dec 2009 | - | 15.76%(-7.4%) |
Sept 2009 | - | 17.02%(-0.8%) |
June 2009 | - | 17.16%(+49.0%) |
Mar 2009 | 10.72%(-24.2%) | 11.52%(+43.6%) |
Dec 2008 | - | 8.02% |
Mar 2008 | 14.14%(+0.4%) | - |
Mar 2007 | 14.08%(-1.9%) | - |
Mar 2006 | 14.35%(-0.8%) | - |
Mar 2005 | 14.46%(-13.2%) | - |
Mar 2004 | 16.66%(-10.6%) | - |
Mar 2003 | 18.63%(+1.6%) | - |
Mar 2002 | 18.33%(+32.4%) | - |
Mar 2001 | 13.84% | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual return on equity?
- What is the all time high annual ROE for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual ROE year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly return on equity?
- What is the all time high quarterly ROE for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly ROE year-on-year change?
What is Takeda Pharmaceutical Company Limited annual return on equity?
The current annual ROE of TAK is 2.09%
What is the all time high annual ROE for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual return on equity is 18.63%
What is Takeda Pharmaceutical Company Limited annual ROE year-on-year change?
Over the past year, TAK annual return on equity has changed by -2.89% (-58.03%)
What is Takeda Pharmaceutical Company Limited quarterly return on equity?
The current quarterly ROE of TAK is 4.01%
What is the all time high quarterly ROE for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly return on equity is 17.16%
What is Takeda Pharmaceutical Company Limited quarterly ROE year-on-year change?
Over the past year, TAK quarterly return on equity has changed by +1.05% (+35.47%)